BILL ANALYSIS
HR8306
BEARISHSCALE Act
HR8306 (SCALE Act) has been assessed with a bearish outlook for investors. This legislation directly affects Advanced Micro Devices ($AMD), NVIDIA ($NVDA) and $SMCI. The primary sectors impacted are Technology. View the full bill text on Congress.gov.
bearish
Market Sentiment
3
Affected Stocks
1
Sectors Impacted
Key Takeaways for Investors
SCALE Act codifies existing AI chip export controls into a predictable annual review; removes 'ban surprise' risk but locks out China revenue growth for NVDA, AMD, SMCI
Zero funding authorized; regulatory mandate only — no new contract opportunities for defense or tech companies
NVDA at $200.67 (near 52-week high) and AMD at $349.37 (near all-time high) already price in strong domestic data center demand; China restriction headwind is incremental negative
How HR8306 Affects the Market
Near-term market impact is muted because the bill merely codifies Biden-era export controls that are already being enforced via Commerce Department rules. The incremental change is predictability—companies know the annual review cycle will occur, reducing the risk of sudden executive orders. For $NVDA and $AMD, this is a modest negative because it formalizes the China revenue ceiling. For domestic hyperscalers like $MSFT and $GOOGL, the impact is neutral to slightly positive as the domestic chip ecosystem gets regulatory stability. $SMCI's recent 7-day decline of 6.3% partially reflects fading enthusiasm from the broader AI server repricing cycle, not specifically the SCALE Act.
Bill Details
| Metric | Value |
|---|---|
| Bill Number | HR8306 |
| Market Sentiment | bearish |
| Event Date | |
| Affected Sectors | Technology |
| Affected Stocks | Advanced Micro Devices ($AMD), NVIDIA ($NVDA), $SMCI |
| Source | View on Congress.gov → |
Summary
The SCALE Act (HR8306) codifies existing AI chip export restrictions into a predictable annual review cycle. For $NVDA, $AMD, and $SMCI, this removes sudden ban risk but locks out China revenue growth. NVDA at $200.67 sits near its 52-week high of $216.83; the stock is down 6.6% from its April 28 close of $213.17. Market is pricing in limited near-term disruption from this early-stage bill.